13 min ago
Inter Press Service
A Matter of Life and Death
Martin Khor, executive director of the South Centre, warns that negotiations on the Trans Pacific Partnership Agreement are a matter of life and death.
Trending on the Topix Network
7 hrs ago
Press and Journal News
Baltacha pledge in liver cancer struggle
The 30-year-old, who retired from the sport last November due to a series of injuries, is undergoing treatment and thanked people for their support.
Sat Mar 08, 2014
Tennis Star Elena Baltacha Battling Liver Cancer
The former U.K. number one, who retired from the sport last year , confirmed her health battle in a statement and vowed to fight the disease.
Fri Mar 07, 2014
Catholic World News
Cardinal George reveals cancer is advancing
Chicago's Cardinal Francis George has disclosed that a cancer in his kidney is showing "signs of new activity," and will require more aggressive treatment.
Elena Baltacha Diagnosed with Liver Cancer
It's been revealed that former British number one tennis player Elena Baltacha has been diagnosed with cancer of the liver.
WNFL-AM Green Bay
Former British number one Baltacha battling cancer
"I have recently been diagnosed with cancer of the liver. I'm currently undergoing treatment and fighting this illness with everything I have," Baltacha, 30, said in a Lawn Tennis Association statement.
Thu Mar 06, 2014
Contra Costa Times
Guest commentary: Hepatitis C is a silent killer, if it is left undiagnosed
A small group of workers and patients from the OASIS clinic march down International Blvd. in Oakland, Calif.
Wed Mar 05, 2014
FDA Gives Bristol-Myers' Daclatasvir And Asunaprevir Breakthrough Designation For Hepatitis C
Bristol-Myers Squibb Company announced in a press release that the Food and Drug Administration has granted a Breakthrough Therapy Designation for a daclatasvir and asunaprevir drug combination.
Rise in Hepatitis C linked to heroin use in St Louis County, state
Dirty needles are to blame for a rising trend in hepatitis C cases in southern St Louis County, that has officials calling the trend a "public health crisis."
Life-Saving Medicine, High Costs, and the Intractable Patent Puzzle
An Indian pharmacologist removes mice from cages to study the reaction of drugs, inside a containment facility in Hyderabad, India on March 13, 2012 In the middle of February, just as another winter snowstorm was about to hit the East Coast, Nina Mahmud flew from her home in Florida to Washington, D.C., to try a Michael Moore-style stunt to save ... (more)
Can low-dose interferon prevent relapse of hepatitis C virus infection?
Journal of Interferon & Cytokine Research , led by Co-Editors-in-Chief Ganes C. Sen, Ph.D., and Thomas A. Hamilton, Ph.D., Chairman, Department of Immunology, Cleveland Clinic Foundation, is an authoritative... New Rochelle, NY, March 5, 2014-Chronic hepatitis C virus infection can lead to serious diseases such as cirrhosis and cancer of the liver, ... (more)
The Washington Post
Hepatitis C Drug Price Limiting State Medicaid Approvals: Health
The price of Gilead Sciences Inc.'s $1,000-a-day hepatitis C pill is keeping state-run Medicaid programs from making it available to many of the people who are most likely to be infected with the disease.
Tue Mar 04, 2014
The face of liver disease could be your own
Unfortunately, this 'who me?' attitude is leading to a rise in complications and deaths due to advanced liver disease.
Medical News Today
Unusual genetic mutation discovered with a link to adolescent liver cancer
In the race for better treatments and possible cures, rare diseases are often left behind.
Mon Mar 03, 2014
Nine-month-old Chloe Simon is in a fight for her life
Baby Chloe Simon is only nine months old but this smiling girl is already undergoing chemotherapy.
Mental Help Net
Nearly 3 Million Americans Living With Hepatitis C
More than 2.7 million Americans are currently infected with liver-damaging hepatitis C, federal officials say, and one expert believes that number could be even higher.
Could new hepatitis C drugs bust state budgets?
Two new drugs have been approved to help millions of Americans who suffer from hepatitis C, but both are extremely expensive.
Facebook helping 2-year-old boy fight cancer
The conversations surrounding a two-year-old boy normally deal with monster trucks, race cars and super heroes.
Gilead leads rivals in race to cure hepatitis C
Gilead Sciences' Sovaldi can cure as many as 90 percent of hepatitis C patients in 12 to 24 weeks.
Sun Mar 02, 2014
Teen helps scientists study her own rare disease
First the teenager survived a rare cancer. Then she wanted to study it, spurring a study that helped scientists find a weird gene flaw that might play a role in how the tumor strikes.